OTHER
About Us
We manufacture and stock quality-assured iPS cells and provide them at a reasonable price to academic research institutions and companies involved in the research and development of regenerative medicine using iPS cells.
News
New Facility for Clinical Cell Manufacturing Named
RESEARCHES
Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing
RESEARCHES
Registration of iPS cell stock (QHJI strain) for clinical use as a U.S. Drug Master File
RESEARCHES
CiRA_F and CIRM Sign Agreement for Widespread Use of iPS Cell Stock
Our Services
iPS Cells
Our iPS cells are being used by more than 60 academic research institutions and companies for basic research and developing new therapies. More than 10 clinical trials have been conducted using our iPS cells.
Bridging Academia and Industry
We transfer iPS cell technology to companies and support their research and development.
Make a Gift
We greatly appreciate your support to further the application and commercialization of
iPS cells for regenerative medicine.